Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Fetal Diagnosis and Therapy
|
January 1, 1997
Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal Graves' disease. A case report
S Heckel, R Favre, J L Schlienger, et al.
Psychosomatics
|
November 6, 2010
Phenytoin toxicity secondary to an oxcarbazepine-phenytoin 2C19 interaction
David P Soskin, Ari J Kane, Theodore A Stern
CNS Neuroscience & Therapeutics
|
June 8, 2012
Antidepressant effects on emotional temperament: toward a biobehavioral research paradigm for major depressive disorder
David P Soskin, Jenna R Carl, Jonathan Alpert, et al.
Clinical Psychology Review
|
February 13, 2013
Positive emotion regulation in emotional disorders: a theoretical review
Jenna R Carl, David P Soskin, Caroline Kerns, et al.
CNS Spectrums
|
August 2, 2013
Incentive salience: novel treatment strategies for major depression
David P Soskin, Daphne J Holt, Garret R Sacco, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
January 1, 1994
[Von Willebrand factor in coronary disease]
P Soskin, M L Wiesel, J M Mossard, et al.
European Heart Journal
|
April 1, 1994
Variation in von Willebrand's Factor according to the treatment of acute myocardial infarction: physiopathological and clinical implications
P Soskin, J M Mossard, R Arbogast, et al.
Journal of Affective Disorders
|
October 14, 2016
Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants
David Mischoulon, Lindsay Hylek, Albert S Yeung, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Fetal Diagnosis and Therapy
|
January 1, 1997
Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal Graves' disease. A case report
S Heckel, R Favre, J L Schlienger, et al.
Psychosomatics
|
November 6, 2010
Phenytoin toxicity secondary to an oxcarbazepine-phenytoin 2C19 interaction
David P Soskin, Ari J Kane, Theodore A Stern
CNS Neuroscience & Therapeutics
|
June 8, 2012
Antidepressant effects on emotional temperament: toward a biobehavioral research paradigm for major depressive disorder
David P Soskin, Jenna R Carl, Jonathan Alpert, et al.
Clinical Psychology Review
|
February 13, 2013
Positive emotion regulation in emotional disorders: a theoretical review
Jenna R Carl, David P Soskin, Caroline Kerns, et al.
CNS Spectrums
|
August 2, 2013
Incentive salience: novel treatment strategies for major depression
David P Soskin, Daphne J Holt, Garret R Sacco, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
January 1, 1994
[Von Willebrand factor in coronary disease]
P Soskin, M L Wiesel, J M Mossard, et al.
European Heart Journal
|
April 1, 1994
Variation in von Willebrand's Factor according to the treatment of acute myocardial infarction: physiopathological and clinical implications
P Soskin, J M Mossard, R Arbogast, et al.
Journal of Affective Disorders
|
October 14, 2016
Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants
David Mischoulon, Lindsay Hylek, Albert S Yeung, et al.
Page
of 1